ANNX
Price
$4.28
Change
+$0.22 (+5.42%)
Updated
Dec 3 closing price
Capitalization
637.96M
95 days until earnings call
Intraday BUY SELL Signals
CLDX
Price
$27.81
Change
+$1.14 (+4.27%)
Updated
Dec 3 closing price
Capitalization
1.85B
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANNX vs CLDX

Header iconANNX vs CLDX Comparison
Open Charts ANNX vs CLDXBanner chart's image
Annexon
Price$4.28
Change+$0.22 (+5.42%)
Volume$1.78M
Capitalization637.96M
Celldex Therapeutics
Price$27.81
Change+$1.14 (+4.27%)
Volume$804.54K
Capitalization1.85B
ANNX vs CLDX Comparison Chart in %
View a ticker or compare two or three
VS
ANNX vs. CLDX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Buy and CLDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ANNX: $4.06 vs. CLDX: $26.66)
Brand notoriety: ANNX and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 110% vs. CLDX: 37%
Market capitalization -- ANNX: $615.6M vs. CLDX: $1.72B
ANNX [@Biotechnology] is valued at $615.6M. CLDX’s [@Biotechnology] market capitalization is $1.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, ANNX is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 6 TA indicator(s) are bullish while CLDX’s TA Score has 7 bullish TA indicator(s).

  • ANNX’s TA Score: 6 bullish, 4 bearish.
  • CLDX’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than ANNX.

Price Growth

ANNX (@Biotechnology) experienced а -8.56% price change this week, while CLDX (@Biotechnology) price change was +0.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

ANNX is expected to report earnings on Mar 09, 2026.

CLDX is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.85B) has a higher market cap than ANNX($638M). CLDX YTD gains are higher at: 5.501 vs. ANNX (-20.858). ANNX has higher annual earnings (EBITDA): -198.44M vs. CLDX (-231.4M). CLDX has more cash in the bank: 630M vs. ANNX (227M). CLDX has less debt than ANNX: CLDX (3.03M) vs ANNX (27.6M). CLDX has higher revenues than ANNX: CLDX (5.79M) vs ANNX (0).
ANNXCLDXANNX / CLDX
Capitalization638M1.85B35%
EBITDA-198.44M-231.4M86%
Gain YTD-20.8585.501-379%
P/E RatioN/AN/A-
Revenue05.79M-
Total Cash227M630M36%
Total Debt27.6M3.03M911%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANNXCLDX
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
81%
Momentum
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
82%
MACD
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 6 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 6 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
86%
Bearish Trend 6 days ago
80%
Advances
ODDS (%)
Bullish Trend 14 days ago
83%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 15 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
82%
Bullish Trend 6 days ago
75%
Aroon
ODDS (%)
Bullish Trend 6 days ago
85%
Bearish Trend 6 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signal:
Gain/Loss:
CLDX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANVIX28.70N/A
N/A
Virtus NFJ Large-Cap Value Fund Inst
DDIIX16.22N/A
N/A
Nomura Wealth Builder Institutional
JMGMX56.72N/A
N/A
JPMorgan Mid Cap Growth R6
BREUX41.71N/A
N/A
Baron Real Estate R6
BOSYX20.02N/A
N/A
BNY Mellon Sm Cp Val Y

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with NRIX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-1.69%
NRIX - ANNX
42%
Loosely correlated
-3.31%
SYRE - ANNX
41%
Loosely correlated
-0.91%
CLDX - ANNX
41%
Loosely correlated
+2.85%
ZYME - ANNX
41%
Loosely correlated
-3.57%
IDYA - ANNX
40%
Loosely correlated
-1.75%
More

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
+2.85%
BEAM - CLDX
55%
Loosely correlated
-2.83%
XNCR - CLDX
54%
Loosely correlated
-3.15%
KURA - CLDX
53%
Loosely correlated
-2.53%
CRNX - CLDX
53%
Loosely correlated
-0.53%
VRDN - CLDX
52%
Loosely correlated
-3.26%
More